Exploring the investible opportunity in life sciences & healthcare in the Asia Pacific region
Based on bespoke research with investors, professionals active in life sciences and healthcare, and advisors who help in the dealmaking process, as well as an in-depth study of recent trends in the space, the Life Sciences & Healthcare Report 2023 from FinanceAsia in partnership with DFIN offers a succinct and yet comprehensive overview of the investible opportunity in a critical sector.